Primary sclerosing cholangitis

Last updated: February 22, 2023

Primary sclerosing cholangitis

Watch later

Watch later

Asthma
Chronic obstructive pulmonary disease (COPD): Clinical
Asthma: Clinical
Epidural hematoma
Subdural hematoma
Intracerebral hemorrhage
Concussion and traumatic brain injury
Hypersensitivity skin reactions: Clinical
Otitis media
Salmonella (non-typhoidal)
Hypertension: Clinical
Hypertension
Hypertension: Pathology review
Hypertensive disorders of pregnancy: Clinical
Eustachian tube dysfunction
Vesiculobullous and desquamating skin disorders: Pathology review
Skin cancer: Pathology review
Viral exanthems of childhood: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Cerebral palsy
Gallbladder disorders: Pathology review
Pulmonary valve disease
Advanced cardiac life support (ACLS): Clinical
Skin anatomy and physiology
Introduction to the somatic and autonomic nervous systems
Hypospadias and epispadias
Abnormal labor: Clinical
Kawasaki disease
Shock
Neonatal ICU conditions: Clinical
Seizures and epilepsy
Antigout medications
Enzyme function
Primary biliary cholangitis
Congenital adrenal hyperplasia
Cirrhosis
Basal ganglia: Direct and indirect pathway of movement
Introduction to the central and peripheral nervous systems
Diabetes mellitus: Clinical
Newborn management: Clinical
Muscarinic antagonists
Primary sclerosing cholangitis
Gallstones
Benign hyperpigmented skin lesions: Clinical
Antiplatelet medications
Nephrotic syndromes: Pathology review
Renal failure: Pathology review
Anatomy clinical correlates: Viscera of the gastrointestinal tract
The role of the kidney in acid-base balance
Gastrointestinal system anatomy and physiology
Chronic kidney disease
Introduction to the immune system
Innate immune system
Hyponatremia
Measuring cardiac output (Fick principle)
Pneumonia: Pathology review
Osteoarthritis
Introduction to pharmacology
Anatomy and physiology of the eye
Optic pathways and visual fields
Photoreception
Wolff-Parkinson-White syndrome
Cor pulmonale
Chronic kidney disease: Clinical sciences
Esophageal cancer
Psoriasis
Appendicitis: Pathology review
Chronic obstructive pulmonary disease: Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Anatomy clinical correlates: Cerebral hemispheres
Ischemic stroke
Stroke: Clinical
Bone tumors: Pathology review
Electrolyte disturbances: Pathology review
Anatomy of the female urogenital triangle
Vertigo: Pathology review
Hypothyroidism
Phenylketonuria (NORD)
Disorders of carbohydrate metabolism: Pathology review
Parasympathetic nervous system
Peripheral artery disease: Pathology review
Nervous system anatomy and physiology
Pain management during labor: Clinical sciences
Childhood oral health: Information for patients and families (The Primary School)
Pneumothorax: Clinical sciences
Blood histology
Non-steroidal anti-inflammatory drugs
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Introduction to the skeletal system
Approach to shock: Clinical sciences
Rheumatoid arthritis

Flashcards

Primary sclerosing cholangitis

0 of 9 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 44-year-old female comes to her primary care PA due to fatigue and intense pruritus for the last 2 months. She works as a schoolteacher and has felt excessive daytime somnolence that is interfering with her job. Past medical history is significant for chronic autoimmune (Hashimoto) thyroiditis, for which she has been taking daily levothyroxine. She drinks 1-2 glasses of wine on the weekends and denies smoking tobacco or using illicit substances. Her temperature is 37.2°C (99.0°F), pulse is 82/min, respirations are 12/min, and blood pressure is 128/82 mmHg. Physical examination reveals multiple excoriations on her trunk and extremities. The liver is palpated 4 cm below the costal margin and is not tender to palpation. Laboratory results are as follows:  

Laboratory value  
Result
TSH
2.2 μU/mL (reference range: 0.5-5 μU/mL)
Total bilirubin  
3.2 mg/dL (reference range: 0.1-1 mg/dL)  
Direct bilirubin  
2.9 mg/dL (reference range: 0.0-0.3 mg/dL)  
Alkaline phosphatase  
455 U/L (reference range: 20-70 U/L)  
AST
81 U/L (reference range: 8-40 U/L)  
ALT
77 U/L (reference range: 8-40 U/L)  
Anti-HBsAg  
Positive (reference range: negative)  
Anti-mitochondrial antibodies  
Positive (reference range: negative)  

Which of the following complications is associated with this patient’s disease process?  

Transcript

Watch video only

Content Reviewers

The name “primary sclerosing cholangitis” or PSC, is actually pretty straightforward, primary refers to it not being known to have been caused by anything else, in other words it isn’t secondary to something else.

Sclerosing means hardening of the tissue and cholangitis is inflammation of the bile ducts.

So with PSC we have this fibrosis and inflammation of both the intra- and extra-hepatic ducts, so inside and outside the liver.

As these cells around the bile ducts become inflamed, die, and harden due to fibrosis, you get this like tightening of the ducts in some areas where there’s been serious fibrosis, and then dilation in other areas that aren’t as affected, and this leads to the classic PSC finding of this sort of “beaded” appearance of the bile ducts.

These areas of fibrosis in the bile ducts can also be seen on histology, and looks a bit like an onion skin since you’ve got these concentric rings of fibrosis around the bile duct, so sometimes it’s referred to as “onion-skin fibrosis”.

Again, with PSC, we don’t really know what causes it right? One clue though is that it’s been known to be associated with ulcerative colitis which is an autoimmune disease and crohn’s disease which is immune-system related; knowing that, PSC’s thought to possibly be an autoimmune disorder itself involving the immune system’s T cells attacking and destroying bile duct epithelial cells.

Why they might start doing this, though, is not very well known, and likely happens in people with certain genetic predispositions when they’re exposed to some specific stimuli in their environment.

Certain genetic factors have been linked to developing PSC; studies have shown that patients with PSC tend to have in common specific human leukocyte antigens, or HLAs.

HLAs are these specific markers on cells that tell your body whether these cells are your own cells or someone else’s cells, and sometimes, for reasons that are usually not well known, the body’s immune system might think that certain HLAs or cell surface markers are foreign even when they’re your own, leading to an autoimmune disorder.

Specific HLA’s that have been common among people with PSC are HLA-B8, HLA-DR3, and HLA-DRw52a.

Another piece of supporting evidence for the autoimmune theory is that most patients with PSC have elevated IgM antibody levels in the serum, as well as an antibody called p-ANCA.

P-ANCA stands for perinuclear anti-neutrophil cytoplasmic antibody, so this is a specific antibody that targets antigens in the cytoplasm or nucleus of neutrophils, the perinuclear part means that the antibody targets an antigen around the nucleus.

Here’s an immunofluorescent image of p-ANCAs, the antibodies in this image are shown in orange, and notice they’ve sort of aggregated around the nucleus, meaning that they bind to an antigen around the nucleus.

A very high proportion, as high as 80%, of patients with PSC have this p-ANCA staining pattern.

Symptoms of PSC are similar to the symptoms of obstructive jaundice, since these “beads” or pinched areas are obstructing the flow of bile.

Also, as these epithelial cells lining the ducts die off, bile can now be allowed to leak out past the cells into the interstitial space, where it can access the bloodstream.

Key Takeaways

Primary sclerosing cholangitis (PSC) is a disease of the bile ducts that causes inflammation and obliterative fibrosis of bile ducts inside and/or outside of the liver. This results in scarring of the biliary tree, which impedes the flow of bile to the intestines and can ultimately lead to cirrhosis of the liver, liver failure, and liver cancer. Symptoms of PSC can include fatigue, itching, jaundice, abdominal pain, and weight loss. If left untreated, PSC can lead to liver failure. Definitive treatment is liver transplant, but ursodeoxycholic acid (UDCA help to slow disease progression and alleviate symptoms.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Primary Sclerosing Cholangitis" New England Journal of Medicine (2016)
  6. "The dynamic biliary epithelia: Molecules, pathways, and disease" Journal of Hepatology (2013)
  7. "Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis" Annals of Hepatology (2014)